Clinical Trials
6
Active:2
Completed:3
Trial Phases
1 Phases
Phase 1:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
6 (100.0%)Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab
Phase 1
Recruiting
- Conditions
- Clear Cell Renal Cell CarcinomaClear Cell Renal Cell Carcinoma Metastatic
- Interventions
- First Posted Date
- 2022-05-06
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Mohammed Milhem
- Target Recruit Count
- 55
- Registration Number
- NCT05363631
- Locations
- 🇺🇸
University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States
Chlorpromazine and Standard of Care in Glioblastoma
Phase 1
Active, not recruiting
- Conditions
- Glioblastoma Multiforme
- Interventions
- First Posted Date
- 2022-01-13
- Last Posted Date
- 2023-08-29
- Lead Sponsor
- Mohammed Milhem
- Target Recruit Count
- 10
- Registration Number
- NCT05190315
- Locations
- 🇺🇸
University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
- First Posted Date
- 2018-04-26
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Mohammed Milhem
- Target Recruit Count
- 25
- Registration Number
- NCT03508726
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial
- First Posted Date
- 2017-06-02
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Mohammed Milhem
- Target Recruit Count
- 17
- Registration Number
- NCT03173976
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma
Phase 1
Completed
- Conditions
- Pancreatic Ductal AdenocarcinomaSarcoma
- Interventions
- First Posted Date
- 2016-11-08
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Mohammed Milhem
- Target Recruit Count
- 36
- Registration Number
- NCT02959164
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
- Prev
- 1
- 2
- Next
News
No news found